<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="100778">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01792609</url>
  </required_header>
  <id_info>
    <org_study_id>MIMO1208M18202</org_study_id>
    <nct_id>NCT01792609</nct_id>
  </id_info>
  <brief_title>Min Implants Max Outcomes Clinical Trial</brief_title>
  <acronym>MIMOCT</acronym>
  <official_title>Minimize Implants Maximize Outcomes (MIMO) Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alfred I. duPont Hospital for Children</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Texas Scottish Rite Hospital for Children</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Colorado</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Norton Leatherman Spine Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital of Philadelphia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St. Justine's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Minnesota - Clinical and Translational Science Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objectives Primary objective: Determine if there is a clinically significant difference in
      percent Cobb curve correction in a low- vs. high-implant density cohort through a
      prospective randomized controlled trial.

      Design and Outcomes Randomized clinical trial of equivalence to test the efficacy and safety
      of low vs. high implant density instrumentation for spine deformity surgery in AIS patients
      with Lenke IA curve patterns.

      Interventions and Duration Intervention: low-implant density group or high-implant density
      group. Duration: 2 years. Sample Size and Population Target population: 10 to 17 years old
      with AIS who will undergo instrumented spinal fusion. Sample size needed (power = 90%) is
      174 subjects with 87 in each group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The MIMO Study Group proposes to conduct a prospective randomized controlled trial in order
      to determine whether a low implant density cohort has equivalent clinical and radiographic
      results to a high implant density cohort. This study is proposed as a trial of equivalence.
      The null hypothesis is that significant differences exist in percent major Cobb angle
      correction between high- and low-implant density cohorts for Lenke 1A curve types, the most
      common scoliotic curve pattern (73). Consecutive qualifying patients will be screened and
      enrolled by high-volume spine surgeons at 14 sites and randomized to spinal instrumentation
      with a low- or high-density screw pattern. Patients will return at 3-months, 1-year, and
      2-years for exam, radiographs, and collection of patient-reported outcome scores. The Harms
      Study Group Foundation will serve as a collaborating organization and will provide database
      development and management, secure online data collection, centralized radiographic
      measurements, and data quality control. The University of Minnesota team will lead study
      design, protocol development, IRB/data use agreement contracts, patient randomization, and
      statistical analysis, including quarterly data review. Imaging will be obtained either with
      an EOS system or using a calibration belt during the radiographs, which allows for
      subsequent with the 3D modeling of the deformity. Six enrolling sites currently have this
      capability (EOS - Montreal, St. Louis, Iowa, Mayo, DuPont, and San Diego). An additional
      five sites already have calibration belts - Dallas, New York, Baltimore, Boston, U. of
      Rochester), and new calibration belts will be fabricated for the additional sites. The
      Montreal site will supervise collection of radiographic data with 3D capability and assist
      with troubleshooting and radiographic quality control. Although the study is primarily
      powered to detect change in percent correction of the major coronal curve, preliminary data
      will be gathered on axial and sagittal plane correction as well as complications, surgical
      factors, and patient-reported outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Cobb Angle</measure>
    <time_frame>pre-surgery ranging 1 year to 1 month and peri surgery at about 3-months, 1-year, and 2-year postoperative</time_frame>
    <description>Radiographic, surgical, and patient-reported data will be gathered and analyzed to observe changes between time points. All radiographs will be taken with 3D analysis capability, either with a calibration belt using standard radiograph techniques or with an EOS imaging system. This will allow for additional detailed correction measures, such as change in spinal rotation (orientation of the planes of maximum curvature) and detailed coronal, sagittal and transverse plane measures. Bending films will be taken according to institutional protocol. The SRS-30, SAQ, and EQ5D will be collected at all clinical visits. Study questions will be aligned as much as possible with other prospective scoliosis protocols so as to minimize patient and surgeon response burden. The study protocol requires no additional visits or radiographs beyond standard of care.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood Loss</measure>
    <time_frame>During surgery, 1 time occurence</time_frame>
    <description>Blood loss amount that occured during the surgical procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative Time</measure>
    <time_frame>1 time measurement, occurs at surgery</time_frame>
    <description>Length of time required to complete surgical procedure in either arm of the study (highest number or lowest number of screws).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3D parameter correction</measure>
    <time_frame>collected during surgical procedure</time_frame>
    <description>Surgeon reported measure of screw manipulation during the surgery.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Scoliosis</condition>
  <condition>Adolescent Idiopathic Scoliosis</condition>
  <arm_group>
    <arm_group_label>Maximum Number of Screws</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Once enrolled and consented, patients with Lenke 1A curves will be randomized to a high- or low-density screw cohort. The high-density pattern will be designated as ≥ 1.8 implants per level fused. The low density pattern will be ≤ 1.4 screws per level fused. At least 75% of the implants must be pedicle screws for both cohorts.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Minimum Number of Screws</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Once enrolled and consented, patients with Lenke 1A curves will be randomized to a high- or low-density screw cohort. The high-density pattern will be designated as ≥ 1.8 implants per level fused. The low density pattern will be ≤ 1.4 screws per level fused. At least 75% of the implants must be pedicle screws for both cohorts.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Maximum Number of Screws</intervention_name>
    <description>The tools used for this arm of study are FDA approved with section 510 (k) K122433. These screws are regularly used in all procedures pertaining to Cobb angle correction surgeries outside of the context of this study.</description>
    <arm_group_label>Maximum Number of Screws</arm_group_label>
    <other_name>Pedicle Screw Spinal System</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Minimum Number of Screws</intervention_name>
    <description>The tools used for this arm of study are FDA approved with section 510 (k) K122433. These screws are regularly used in all procedures pertaining to Cobb angle correction surgeries outside of the context of this study.</description>
    <arm_group_label>Minimum Number of Screws</arm_group_label>
    <other_name>Pedicle Screw Spinal System</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged ≥10 and ≤ 18 years

          -  Male or Female

          -  Diagnosis of idiopathic scoliosis for which surgery is recommended to prevent the
             curvature or to correct trunk disfigurement Lenke 1A curve pattern

          -  Curve cobb of 45° to 65°

          -  T5-T12 kyphosis measuring 0° to 40°

          -  Spina bifida Oculta is permitted

          -  Spondylolisthesis and Spondylolysis are permitted, as long as non- operative

        Exclusion Criteria:

          -  Prior spinal surgery

          -  MRI abnormalities (including &gt;4mm of Syrinx and/or Chiari malformation)

          -  Neuromuscular or other serious co-morbidities

          -  Thoracogenic or cardiogenic scoliosis

          -  Associated syndrome or developmental delay

          -  Unable or unwilling to firmly commit to returning for required follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David W Polly, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota - Clinical and Translational Science Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David W Polly, MD</last_name>
    <phone>612-273-7983</phone>
    <email>pollydw@umn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Charles Ledonio, MD</last_name>
    <phone>612-273-8035</phone>
    <email>ledon001@umn.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nikki Bloch</last_name>
      <phone>720-777-5809</phone>
      <email>Nikki.Bloch@childrenscolorado.org</email>
    </contact>
    <investigator>
      <last_name>Mark Erickson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nemours/ Alfred I. duPont Hospital for Children</name>
      <address>
        <city>Wilmington</city>
        <state>Delaware</state>
        <zip>19803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Geraldine Neiss</last_name>
      <email>Geraldine.Neiss@nemours.org</email>
    </contact>
    <contact_backup>
      <last_name>Petya Yorgova</last_name>
      <email>Petya.Yorgova@nemours.org</email>
    </contact_backup>
    <investigator>
      <last_name>Suken Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Research Institute</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010-2916</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allison Matthews</last_name>
      <phone>202-476-4652</phone>
      <email>amatthew@childrensnational.org</email>
    </contact>
    <investigator>
      <last_name>Matthew Oetgen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Phillips, MPH, CPH</last_name>
      <phone>352-273-7343</phone>
      <email>phillsa@ortho.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Laurel Blakemore, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30329</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Bush, Ed.D.</last_name>
      <phone>404-778-1563</phone>
      <email>patricia.a.bush@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Nicholas Fletcher, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lori Dolan, PhD</last_name>
      <phone>319-356-1075</phone>
      <email>lori-dolan@uiowa.edu</email>
    </contact>
    <investigator>
      <last_name>Stuart Weinstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Norton Leatherman Spine Center</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Bratcher, RN, CCRP</last_name>
      <phone>502-992-0488</phone>
      <phone_ext>131</phone_ext>
      <email>Kelly.bratcher2@nortonhealthcare.org</email>
    </contact>
    <investigator>
      <last_name>Leah Carreon, MD, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Craig Remenapp, MS</last_name>
      <phone>410-502-6442</phone>
      <email>cremena1@jhmi.edu</email>
    </contact>
    <investigator>
      <last_name>Paul Sponseller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55454</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Ledonio, MD</last_name>
      <phone>612-273-8035</phone>
      <email>ledon001@umn.edu</email>
    </contact>
    <investigator>
      <last_name>David W Polly, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charles G Ledonio, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Noelle Larson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noelle A Larson, MD</last_name>
      <phone>507-244-0093</phone>
      <email>Larson.Noelle@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Noelle A Larson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Washington University in St. Louis</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brenda Sides, RN</last_name>
      <phone>314-747-2588</phone>
      <email>sidesb@wudosis.wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Munish Gupta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Rochester</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14618</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krista Noble</last_name>
      <phone>585-341-9303</phone>
      <email>Krista_Noble@urmc.rochester.edu</email>
    </contact>
    <investigator>
      <last_name>James Sanders, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Scottish Rite Hospital for Children</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaitlyn Brown, BS</last_name>
      <phone>214-559-8547</phone>
      <email>Kaitlyn.Brown@tsrh.org</email>
    </contact>
    <investigator>
      <last_name>B.Stephens Richards, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Sucato, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Sainte-Justine</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3T1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Soraya Barchi</last_name>
      <phone>5143454931</phone>
      <phone_ext>4352</phone_ext>
      <email>soraya.barchi@umontreal.ca</email>
    </contact>
    <investigator>
      <last_name>Hubert Labelle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <lastchanged_date>May 13, 2016</lastchanged_date>
  <firstreceived_date>January 22, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Scoliosis</keyword>
  <keyword>Cobb Angle</keyword>
  <keyword>Screw Density</keyword>
  <keyword>Outcomes Measures</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Scoliosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
